| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/27/2000 | WO2000043035A1 Amino acid-containing albumin preparations |
| 07/27/2000 | WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043010A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 07/27/2000 | WO2000043001A1 Anti-inflammatory agents |
| 07/27/2000 | WO2000042992A2 Compositions and methods for mucosal delivery |
| 07/27/2000 | WO2000042987A2 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
| 07/27/2000 | WO2000042975A1 Preparation for dental treatment |
| 07/27/2000 | WO2000042864A2 Methods for reducing mortality rates in poultry |
| 07/27/2000 | WO2000042852A1 Compounds and methods |
| 07/27/2000 | WO2000023574A3 Hepatitis a vaccines |
| 07/27/2000 | WO2000023068A3 Fumaric acid microtablets |
| 07/27/2000 | WO2000018915A3 Membrane-associated organizational proteins |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | DE19902773A1 Anticholestatische Wirksamkeit von Luteolin Anticholestatic effectiveness of luteolin |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2360730A1 Human liver progenitors |
| 07/27/2000 | CA2360038A1 Methods for reducing mortality rates in poultry |
| 07/27/2000 | CA2359983A1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359105A1 New morpholinobenzamide salts |
| 07/27/2000 | CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | CA2358524A1 Compositions and methods for mucosal delivery |
| 07/27/2000 | CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2355168A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/26/2000 | EP1022024A2 Anticholestatic activity of luteolin, apigenin and naringenin |
| 07/26/2000 | EP1022023A1 Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora |
| 07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
| 07/26/2000 | EP1021456A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b |
| 07/26/2000 | EP1021444A1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES |
| 07/26/2000 | EP1021442A1 8-azabicyclo 3.2.1] octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors |
| 07/26/2000 | EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION |
| 07/26/2000 | EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/26/2000 | EP1021406A1 Novel anandamide amidase inhibitors as analgesic agents |
| 07/26/2000 | EP1021204A2 Bioadhesive compositions and methods for topical administration of active agents |
| 07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 07/26/2000 | EP1021196A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 07/26/2000 | EP1021193A1 THERAPEUTICALLY EFFECTIVE 1$g(a), 25-DIHYDROXYVITAMIN D 3? ANALOGS |
| 07/26/2000 | EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity |
| 07/26/2000 | EP1021181A1 Carboxylic acid indole inhibitors of chemokines |
| 07/26/2000 | EP1021174A2 Medicaments |
| 07/26/2000 | EP1021171A1 Delayed total release gastrointestinal drug delivery system |
| 07/26/2000 | EP1021087A1 Serotonin containing formulation for oral administration and method of use |
| 07/26/2000 | CN1261362A Omeprazole sodium salt |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1261276A Protease inhibitors |
| 07/26/2000 | CN1261073A Tricyclooxime ethers, preparations thereof and medicinal compositions containing them |
| 07/26/2000 | CN1260992A Medicine for treating calculosis and application method thereof |
| 07/26/2000 | CN1260985A Chinese patent medicine for treating gastroptosis |
| 07/26/2000 | CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical |
| 07/26/2000 | CN1054850C Piperazine compounds used in therapy |
| 07/26/2000 | CN1054775C Method for treating hepatitis B carriers with minimal disease |
| 07/26/2000 | CN1054763C Specific remedy for curing dysentery and diarrhea of domestic animals and poultry |
| 07/26/2000 | CN1054760C Yatongxiao for curing toothache and preparation thereof |
| 07/26/2000 | CN1054755C Stomachic tablet and its production method |
| 07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 07/25/2000 | US6093743 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/25/2000 | US6093738 Imidazo(1,2-d)-thiadiazole compounds; peptic ulcer treatment |
| 07/25/2000 | US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 07/25/2000 | US6093716 Substituted 2-pyrimidineamines and processes for their preparation |
| 07/25/2000 | US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases |
| 07/25/2000 | US6093561 Human lysophospholipase |
| 07/25/2000 | US6093394 Vaginal lactobacillus medicant |
| 07/25/2000 | CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 07/25/2000 | CA2167688C Methods and compositions for inhibiting uridine secretion |
| 07/25/2000 | CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| 07/20/2000 | WO2000042429A2 In vitro model for gastrointestinal inflammation |
| 07/20/2000 | WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042168A2 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | WO2000042070A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | WO2000042063A2 Peptides for inhibiting hbv core proteins |
| 07/20/2000 | WO2000042044A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 07/20/2000 | WO2000042029A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000041994A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/20/2000 | WO2000041719A1 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders |
| 07/20/2000 | WO2000041707A2 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 07/20/2000 | WO2000041705A1 Pre-conditioning against cell death |
| 07/20/2000 | WO2000041576A1 Improved microbial preparations |
| 07/20/2000 | WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | WO2000041505A2 Anthranilic acid derivatives |
| 07/20/2000 | WO2000041463A2 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | WO2000031141B1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 07/20/2000 | WO2000021979A3 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 07/20/2000 | WO2000021521A3 Sertraline oral concentrate |
| 07/20/2000 | WO2000014097A3 Novel pyranoses |
| 07/20/2000 | WO2000001687A9 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 07/20/2000 | WO1997025042A8 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
| 07/20/2000 | DE19901009A1 Peptide zur Inhibierung von HBV-Core-Proteinen Peptides to inhibit HBV core proteins |
| 07/20/2000 | CA2724287A1 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |